STOCK TITAN

AbbVie Declares Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Rhea-AI Summary
AbbVie Inc. (NYSE: ABBV) has declared a quarterly cash dividend of $1.48 per share. The dividend is payable on August 15, 2023, to stockholders of record on July 14, 2023. AbbVie has increased its dividend by 270 percent since its inception in 2013 and is a member of the S&P Dividend Aristocrats Index.
Positive
  • AbbVie Inc. has declared a quarterly cash dividend of $1.48 per share, which indicates a positive outlook for investors. The company has consistently increased its dividend by 270 percent since 2013, showcasing its commitment to rewarding shareholders. Being a member of the S&P Dividend Aristocrats Index further strengthens AbbVie's reputation as a stable and reliable investment option.
Negative
  • None.

NORTH CHICAGO, Ill., June 22, 2023 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.48 per share. 

The cash dividend is payable August 15, 2023, to stockholders of record at the close of business on July 14, 2023.

Since the company's inception in 2013, AbbVie has increased its dividend by 270 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-301858393.html

SOURCE AbbVie

FAQ

What is the dividend declared by AbbVie Inc.?

AbbVie Inc. has declared a quarterly cash dividend of $1.48 per share.

When will the dividend be paid?

The dividend will be payable on August 15, 2023.

Who is eligible to receive the dividend?

Stockholders of record at the close of business on July 14, 2023, will be eligible to receive the dividend.

How much has AbbVie Inc. increased its dividend by since its inception?

AbbVie Inc. has increased its dividend by 270 percent since its inception in 2013.

What is the significance of being a member of the S&P Dividend Aristocrats Index?

Being a member of the S&P Dividend Aristocrats Index indicates that AbbVie Inc. has annually increased its dividend for at least 25 consecutive years, highlighting its stability and reliability as an investment option.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

286.35B
1.76B
0.11%
71.92%
0.74%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NORTH CHICAGO

About ABBV

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.